Page last updated: 2024-09-04

13-oxo-9,11-octadecadienoic acid and Malaria

13-oxo-9,11-octadecadienoic acid has been researched along with Malaria in 1 studies

*Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergström, S; Bonde, M; Gouveia-Figueira, S; Lindquist, E; Magambo, J; Muhinda, C; Normark, J; Orikiiriza, J; Surowiec, I; Trygg, J1

Other Studies

1 other study(ies) available for 13-oxo-9,11-octadecadienoic acid and Malaria

ArticleYear
The oxylipin and endocannabidome responses in acute phase Plasmodium falciparum malaria in children.
    Malaria journal, 2017, 09-08, Volume: 16, Issue:1

    Topics: Arachidonate 5-Lipoxygenase; Biomarkers; Child; Child, Preschool; Cytochrome P-450 Enzyme System; Endocannabinoids; Female; Humans; Infant; Linoleic Acids; Linoleic Acids, Conjugated; Linolenic Acids; Malaria; Malaria, Falciparum; Male; Multivariate Analysis; Oxylipins; Plasmodium falciparum; Rwanda

2017